CARFILZOMIB
carfilzomib 10 mg injection, 1 vial
CARFILZOMIB (12243J)
12243J
Manner of administration:Injection
Restriction 12694
Indication: Multiple myeloma
Treatment phase: Initial treatment - once weekly treatment regimen
Restriction 12849
Indication: Multiple myeloma
Treatment phase: Continuing treatment - once weekly treatment regimen
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 160 mg | # of repeats: 8 | DPMA: $3,396.56 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Kyprolis
(carfilzomib 10 mg injection, 1 vial)
|
||||
| Kyprolis
(carfilzomib 30 mg injection, 1 vial)
|
||||
| Kyprolis
(carfilzomib 60 mg injection, 1 vial)
|
||||